1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: A landmark analysis
    Journal Article

    Berdeja, J. G.; Heinrich, M. C.; Dakhil, S. R.; Goldberg, S. L.; Wadleigh, M.; Kuriakose, P.; Cortes, J.; Radich, J.; Helton, B.; Rizzieri, D.; more...
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma
    Journal Article

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer
    Journal Article

    McHugh, D.; Eisenberger, M.; Heath, E. I.; Bruce, J.; Danila, D. C.; Rathkopf, D. E.; Feldman, J.; Slovin, S. F.; Anand, B.; Chu, R.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Mutations in spliceosome genes and therapeutic opportunities in myeloid malignancies
    Review

    Taylor, J.; Lee, S. C.
    Genes Chromosomes and Cancer (2019)

    Fulltext@MSK | Save
  • Cobimetinib-induced “dropped head syndrome” and subsequent disease management in an Erdheim-Chester patient
    Journal Article

    King, A. C.; Diamond, E. L.; Orozco, J. S.; Morse, H. R.; Ouyang, L. L.; Schöder, H.; Rampal, R. K.
    Clinical Case Reports (2019)

    Fulltext@MSK | Save
  • Differentiation syndrome in acute promyelocytic leukaemia
    Review

    Stahl, M.; Tallman, M. S.
    British Journal of Haematology (2019)

    Fulltext@MSK | Save
  • CAR-T – and a side order of IgG, to go? – Immunoglobulin replacement in patients receiving CAR-T cell therapy
    Review

    Hill, J. A.; Giralt, S.; Torgerson, T. R.; Lazarus, H. M.
    Blood Reviews (2019)

    Fulltext@MSK | Save
  • Lymphocyte-to-monocyte ratio may serve as a better prognostic indicator than tumor-associated macrophages in DLBCL treated with rituximab
    Journal Article

    Matsuki, E.; Bohn, O. L.; El Jamal, S.; Pichardo, J. D.; Zelenetz, A. D.; Younes, A.; Teruya-Feldstein, J.
    Applied Immunohistochemistry & Molecular Morphology (2019)

    Fulltext@MSK | Save